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The Hedgehog (HH) signaling pathway is a central regulator of embryonic development, controlling the
pattern and proliferation of a wide variety of organs. Previous studies have implicated the secreted
protein, Scube2, in HH signal transduction in the zebraﬁsh embryo (Hollway et al., 2006; Kawakami
et al., 2005; Woods and Talbot, 2005) although the nature of the molecular function of Scube2 in this
process has remained undeﬁned. This analysis has been compounded by the fact that removal of
Scube2 activity in the zebraﬁsh embryo leads to only subtle defects in HH signal transduction in vivo
(Barresi et al., 2000; Hollway et al., 2006; Ochi and Westerﬁeld, 2007; van Eeden et al., 1996; Wolff
et al., 2003). Here we present the discovery of two additional scube genes in zebraﬁsh, scube1 and
scube3, and demonstrate their roles in facilitating HH signal transduction. Knocking down the function
of all three scube genes simultaneously phenocopies a complete loss of HH signal transduction in the
embryo, revealing that Scube signaling is essential for HH signal transduction in vivo. We further deﬁne
the molecular role of scube2 in HH signaling.
& 2012 Elsevier Inc. All rights reserved.Introduction
HH signaling plays signiﬁcant roles in normal embryonic
development and erroneous HH signaling leads to human disease
(reviewed in Bale, 2002; Cohen, 2003; Mullor et al., 2002;
Nieuwenhuis and Hui, 2005; Taipale and Beachy, 2001; Wicking
and McGlinn, 2001). Mutations in components of the HH signal
transduction pathway have been directly implicated as causative
in a number of developmental abnormalities, such as craniofacial
and polydactyly conditions (Hui and Joyner, 1993; Kang et al.,
1997; Radhakrishna et al., 1997; Roessler et al., 1996; Vortkamp
et al., 1991). In addition, mutation and mis-regulation of HH
signaling components are present in a wide variety of malignant
tissues (reviewed in Evangelista et al., 2006). Many of the genes
that regulate Hedgehog signal transduction have been identiﬁedll rights reserved.
enerative Biology, Australian
elbourne, VIC 3800, Australia.
dical Research, Darlinghurst,
ollway),
ogy and Biochemistry, Simonand the majority of the molecular components are conserved
from Drosophila melanogaster through to vertebrates (Hooper and
Scott, 2005; Ingham and McMahon, 2001). In its most basic form
the pathway involves reception of the secreted HH glyco-protein
signal by the transmembrane receptor Patched, which in the
absence of ligand inhibits the activity a second transmembrane
receptor, Smoothened. When HH ligand is present, Smoothened
inhibition is released, leading to activation of the Gli transcription
factor and transcription of HH target genes.
In the developing zebraﬁsh embryo, HH signaling speciﬁes two
different muscle ﬁber types, slow twitch and fast twitch muscle
(Blagden et al., 1997, Du et al., 1997). Varying levels of HH
signaling are required to specify the different cell types found
within the myotome; high levels of HH are required to induce the
Engrailed (En) positive muscle pioneer slow cells (MPs) and the
En positive medial fast ﬁbers, while lower concentrations of HH
specify the non-pioneer slow twitch muscle ﬁbers, which arise
from the adaxial cells adjacent to the notochord and migrate
laterally to form a superﬁcial layer of slow muscle (Blagden et al.,
1997; Currie and Ingham, 1996; Wolff et al., 2003). Fast muscle
ﬁbers differentiate after slow muscle migration has begun and are
thought to receive the lowest amount of HH signal (Ochi and
Westerﬁeld, 2007; Wolff et al., 2003). The you-type group of
zebraﬁsh mutants have ‘‘U’’-shaped rather than chevron-shaped
somites and disrupt the formation of cell fates that are known to
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cells (van Eeden et al., 1996) and many of the you-type mutants
possess mutations in genes encoding HH signaling pathway com-
ponents (Barresi et al., 2000; Hollway et al., 2006; Karlstrom et al.,
1999; Kawakami et al., 2005; Woods and Talbot, 2005).
Mutations in the coding region of the gene scube2were identiﬁed
in multiple alleles of a canonical member of the you-type mutant
class, termed you (Hollway et al., 2006; Kawakami et al., 2005;
Woods and Talbot, 2005). you mutants display the weakest pheno-
type of the class, with a reduction in MPs and a variable reduction of
the slow twitch muscle cell population (Lewis et al., 1999; Hollway
et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005). you
mutants demonstrate an anterior to posterior progression in their
phenotype whereby the loss of HH sensitive fates becomes more
severe in the posterior of the embryo (Hollway et al., 2006).
Expression of the HH receptor ptc and the muscle speciﬁc transcrip-
tion factor myod, both sensitive to HH signaling, are reduced in the
posterior adaxial cells of you homozygous mutant embryos (Hollway
et al., 2006; Kawakami et al., 2005; Lewis et al., 1999; Woods and
Talbot, 2005) but remain relatively unaffected in anterior somites.
Scube2, a member of the signal peptide-CUB domain-EGF-
related (scube) gene family, was ﬁrst identiﬁed in mouse as a
novel gene encoding an epidermal growth factor (EGF)-related
protein containing a CUB domain (Grimmond et al., 2000). Three
distinct scube gene family members have been identiﬁed and
called scube1–3, based on their order of discovery in mammals
(Grimmond et al., 2000; Grimmond et al., 2001; Wu et al., 2004;
Yang et al., 2002). Scube family proteins contain a conserved
domain organization, consisting of an N-terminal domain con-
taining nine EGF-like repeats of the calcium binding class, and a
single CUB (Complement subcomponents C1r/C1s, EGF related sea
urchin protein, bone morphogenetic protein-1) domain near the
C-terminus. The EGF-like repeats and CUB domain are linked by a
spacer region and are thought to be involved in protein-protein
interactions and ligand binding. Additionally the Scube proteins
are known to be secreted and cell-surface associated (Grimmond
et al., 2000; Wu et al., 2004; Yang et al., 2002). Homodimerization
has been demonstrated for all three human SCUBE proteins, while
hSCUBE1 has been shown to heterodimerize with both hSCUBE2
and hSCUBE3 (Wu et al., 2004; Yang et al., 2002).
Despite previous studies (Hollway et al., 2006; Kawakami
et al., 2005; Woods and Talbot, 2005) the exact nature of Scube2’s
role in Hedgehog signaling remains elusive. We and others have
previously shown, using transplants between you mutant and
wildtype embryos, that scube2 is required non-cell autonomously
for correct speciﬁcation of HH target cells, (Hollway et al., 2006;
Woods and Talbot, 2005). These and other analyses suggest that
Scube2 may be required for the transport or stability of the HH
signal (Hollway et al., 2006; Woods and Talbot, 2005). The notion
that Scube2 may act upstream or adjacent to reception of the HH
signal is reinforced by studies that show components of the HH
signaling pathway downstream of Shh are functional in Scube2
mutants (Hollway et al., 2006).
Given the lack of a universally accepted mode of action for
Scube2, we sought to further characterize the role of the Scube gene
family in HH signaling. The youty97 mutant phenotype is relatively
weak compared to other you-type mutants, and thus its central
importance to HH signal transduction has remained unclear. The
existence of three scube genes in both mouse and humans suggested
there might also be additional scube genes functioning in HH
signaling in zebraﬁsh, and that the original models of Scube2 function
in HH signal transduction may have been confounded by redundant
action of the Scube protein class. In this study, we have determined
there are three scube genes in zebraﬁsh and that all three genes play
a role in HH signaling and slow muscle development in the
zebraﬁsh embryo, and that combined knockdown of function forall three scube genes completely abrogates HH signaling in the
zebraﬁsh embryo. We also further show that despite being
required for normal HH signal transduction in vivo the necessity
for collective scube activity can be overcome with application of
sufﬁcient HH ligand.Results
Identiﬁcation and mRNA expression of scube1 and 3 genes in
zebraﬁsh
Mouse, human and chicken scube1 and scube3 sequences were
used to identify partial, orthologous sequences within the integrated
Whole Genome Shotgun (WGS) assembly of the zebraﬁsh genome
available at Ensembl (www.ensembl.org/Danio_rerio/Info/Index).
Partial sequences of two zebraﬁsh scube genes, additional to scube2,
were identiﬁed and assembled using Genewise (http://www.ebi.ac.
uk/Tools/Wise2/index.html). Following RACE, full-length sequences
corresponding to the predicted partial sequences were isolated from
a zebraﬁsh cDNA library (GenBank accession numbers JF900367
(scube1) and JF900368 (scube3)). Alignment of the corresponding
protein sequences for zebraﬁsh Scube1 and Scube3 with mouse and
human Scube orthologues, showed high homology across these
species for both Scube1 and Scube3 proteins (Fig. S1 and data not
shown). No additional scube sequences were identiﬁed in the
zebraﬁsh genome. Analysis of the zebraﬁsh Scube1 and Scube3
protein sequences determined these Scube family members also
have the signal peptide, EGF repeats, CUB domains and spacer
regions found in Scube2 and all known Scube family members.
Zebraﬁsh Scube1 and Scube3 proteins cluster with their mouse and
human orthologues in a phylogenetic tree (Fig. S1). Sequence
regions of low similarity between the three zebraﬁsh scube genes
were used to design in situ hybridization probes for each gene. This
analysis revealed that scube1 is maternally expressed (Fig. 1A) and at
90% epiboly is expressed in the developing notochord (Fig. 1B).
From 1–2 somites, embryos exhibit diffuse neural and hindbrain
staining, weak expression in the pre-somitic mesoderm (psm) and
notochord which persists at the 15 somite stage (Fig. 1C). At later
somite stages embryos exhibit stronger scube1 expression in the
somitic mesoderm and notochord, as well as in the forebrain,
midbrain, hindbrain and rhombomeres (Fig. 1D, E). Analysis of
histological sections conﬁrmed expression within speciﬁc regions
of the neural tube and brain, with strong expression in the ﬂoorplate
and lateral ventral regions of the neural tube, areas known to be
patterned by HH signal transduction (Fig. 1F, G, I). Expression within
the somitic mesoderm was also conﬁrmed via sectioning (Fig. 1H).
Maternal expression of scube3 was also found (Fig. 1J), early somite
stages exhibited expression in the notochord, developing somites as
well as diffuse neural expression. The neural, notochord, somitic
mesoderm and presomitic mesoderm staining persisted throughout
somitogenesis (Fig. 1K). Strong ﬂoorplate expression and weak
notochord expression is evident at the 26 somite stage, which
shows an anterior (high) to posterior (low) gradient of expression
(Fig. 1L–P). Weak somitic mesoderm expression of scube3 is also
evident at this stage. In summary scube1 and scube3 are expressed
within tissues that are known to secrete HH or are patterned by HH,
although clear exceptions to this can be seen, that hint at a broader
role for Scube proteins than modulation of HH signaling alone.
Morpholino knockdown of scube1 and scube3 expression enhances
the phenotype of the scube2 mutant, youty97
The weak phenotype of youty97 mutant embryos, compared
with other members of the you-type class (Hollway et al., 2006;
van Eeden et al., 1996), together with the overlapping nature of
Fig. 1. mRNA expression patterns of scube1 and scube3. (A–I) scube1 mRNA expression. (A) Maternal expression of scube1 in 256 cell embryo, (B) scube1 is expressed in a
stripe of cells corresponding to the developing notochord (nc) at 90% epiboly. (C) At 15 somites, scube1 is expressed in the somitic mesoderm (sm), and notochord. (D, E)
At 26 somites scube1 expression is in the forebrain (fb), olfactory bulb (ob), midbrain (mb), hindbrain (hb), rhombomeres (bracket), with diffuse staining present in
notochord and ﬂoorplate (fp) of neural tube [E closeup of axial somites in embryo equivalent to D]. (F–I) Sections of 24 hpf embryos. (F) scube1 expression in forebrain,
cerebellar neurons (cb), lens (ln), optic cup (oc) with strong expression in the olfactory (ol) forebrain region. (G, I) scube1 is expressed throughout the neural tube (nt) with
strong ﬂoorplate and lateral nt expression. (H, I) scube1 somitic mesoderm expression in tail sections. (J–P) scube3mRNA expression. (J) Maternal expression of scube3 in 256
cell embryo. (K) scube3 expression in the ﬂoorplate, notochord, somitic mesoderm, and PSM at 15 somites. (L, M) Extensive neural expression (telencephalon te, diencephalon,
di, midbraim, mb, and hindbrain, hb), expression in the ﬂoorplate, somites and diffusely in the notochord at 26 somites. (M) Magniﬁcation of tail region in (L) showing strong
ventral ﬂoorplate staining and weak notochord staining. N–P sections of 24 hpf embryos. (N) scube3 is expressed in the cerebellum, the lens of the eye and the optic cup and
weakly in the forebrain. (O) scube3 expression is strong in sclerotome ventral to the notochord. (P) scube3 expression throughout neural tube, strong expression in ﬂoorplate
and weak notochord expression. Scale Bars: 100 mm. (C, K) Dorsal view, (D, E, L, M) lateral view (F, H, N) longitudinal sections, (G, I, O, P) transverse sections.
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three scube genes may be functioning redundantly in HH signaling
and slow muscle development. Alternatively, it remained formally
possible that the allele of scube2mostly utilised for analyses, youty97,
which is predicted to encode a truncated form of Scube2 missing the
C-terminal 443 amino acids, is not a complete null allele. In order to
distinguish between these hypotheses, 41.1Zg of scube2MO was
injected into homozygous youty97 mutant embryos. Consistent with
youty97 being a null allele of scube2, injection of the scube2MO did
not appear to alter the youty97 phenotype (n¼15) (data not shown)
and the loss of slow muscle ﬁbers in the posterior of homozygous
youty97 embryos injected with scube2MO, does not appear to be
more severe than youty97 alone.
To investigate the possibility of functional redundancy acting
between the scube encoding genes, translation-blocking morpho-
linos to scube1 and scube3 were injected, individually and in
combination, into wildtype and youty97 embryos. In homozygous
youty97 mutant embryos, in addition to U-shaped somites, there is
a loss of slow twitch muscle ﬁbers in the posterior tail and the
ordered array of ﬁbers becomes patchy, slow myosin heavy chain
(MyHC) positive muscle ﬁbers are often absent from the tip of the
tail (Fig. 2B). Injection of scube1 MO or scube3 MO individually
into wildtype embryos did not alter the ordered slow muscle ﬁber
array (n¼40 for each morpholino) (Fig. 2C, E), although scube1
morphants appear to have a shorter body axis indicative of a mild
axis extension defect (Fig. S2). Furthermore co-injection of scu-
be1MO and scube3MO into wildtype embryos, also failed to cause an
effect on the slow MyHC staining pattern (n¼50), and the gross
phenotype resembled that of embryos injected with scube1MO alone
(Fig. 2C, G, Fig. S2). In contrast to the injections into wildtype
embryos, injection of scube1MO or scube3MO into homozygous
youty97 embryos elicited a dramatic ﬁber loss phenotype, enhancing
the phenotype seen in homozygous youty97 mutant embryos. Homo-
zygous youty97 embryos injected with scube1MO have very little or noslow MyHC staining in the ﬁrst 10–12 somites (Fig. 2D) (n¼44).
Posterior to this level, slow muscle formation occurs normally within
yolk extension level somites until the posterior tail at which point the
staining pattern reﬂects the slow muscle loss normally seen in
homozygous youty97 embryos (Fig. 2B, D). In addition to the enhanced
ﬁber loss, youty97þscube1MO injected embryos possessed somites
more rounded in appearance than uninjected homozygous youty97
embryos (data not shown). Intriguingly, homozygous youty97 embryos
injected with scube3MO display a distinct phenotype, where normal
slow MyHC staining is evident in the most anterior 9 somites, after
which the somites completely lack slowMyHC posterior of this point
(Fig. 2F) indicating that distinct scube genes act at different anterior–
posterior regions of the embryo (n¼30).
Notably, morpholino knockdown of scube1 and scube3 in homo-
zygous youty97 mutant embryos resulted in an almost complete
absence of slow MyHC ﬁbers at all axial levels (Fig. 2H), in addition
to a total loss of the wildtype chevron somite shape, resulting in
block-like somites (Fig. 3C, F) (n¼25). To conﬁrm the phenotypic
enhancement of scube1MO or scube3MO occurred only in homo-
zygous youty97 mutant embryos, injected embryos were genotyped.
All scube1MO into youty97 embryos displaying the enhanced ﬁber
loss phenotype were found to be homozygous for the youty97
mutation (n¼44), similar results were found for scube3MO injec-
tions (n¼30) and scube1MOþscube3MO injections (n¼25). Geno-
typing of ten embryos unaffected by each morpholino injection
showed they were either wildtype or youty97 heterozygote embryos.
Importantly, morpholino knockdown of all three scube genes simul-
taneously, scube1MOþscube2MOþscube3MO, hereafter referred to
as scube triple MO embryos, in wildtype embryos produced a
phenotype equivalent to youty97þscube1MOþ scube3MO (Figs. 2H,
I, 3C) (n¼34).
Homozygous youty97 mutant embryos have reduced expression
of the HH target genes myod, patched1 (ptc1) and engrailed
(eng) (Fig. 3J–L) (Hollway et al., 2006; Kawakami et al., 2005;
Fig. 2. scube1 and scube3 morpholinos enhance the phenotype of youty97 mutant
embryos. The wildtype pattern of slow MyHC (A) is disrupted in the posterior tail
region of youty97 homozygotes (B) (arrow). The pattern of slow MyHC is not visibly
affected when scube1MO (C) scube3MO (E) or both scube1MOþscube3MO (G) are
injected into wildtype embryos. (D) scube1MO injected into youty97 homozygotes
enhanced the youty97 phenotype. Slow MyHC expression is disrupted after somite 6,
however slow MyHC expression returns in the posterior somites reﬂecting the pattern
seen in youty97 homozygotes in this region (compare B to D). Bracket highlights the
region in youty97þscube1MO embryos lacking slow MyHC ﬁbers. An arrow indicates
the somitic region where slow MyHC expression resembles youty97 mutants. (F)
scube3MO injected into youty97 homozygotes also enhanced the youty97 mutant
phenotype. Slow MyHC is disrupted after 8–10 somites, all remaining somites
completely lack slow MyHC expression. Bracket highlights the somitic region in
youty97þscube3MO embryos devoid of slow MyHC staining. (H) Injection of scube1-
MOþscube3MO together into youty97 mutant embryos essentially eliminates slow
MyHC staining. Arrows highlight the few remaining slow MyHC positive ﬁbers
remaining in youty97þscube1MOþscube3MO embryos (H). Scube triple MO injection
into wildtype embryos faithfully reproduces the phenotype seen in youty97þ
scube1MOþscube3MO (H and data not shown). All embryos30 hpf. F59 monoclonal
antibody labels slow MyHC positive muscle ﬁbers, Alexa 488-conjugated donkey anti-
mouse secondary. (I) Slow MyHC positive muscle ﬁbers were counted in anterior (1–6
somites), middle (7–15 somites) and posterior (16–30) somites of wildtype, youty97
homozygous mutants, youty97þscube1MO embryos, youty97þscube3MO embryos,
youty97þscube1MOþ scube3MO embryos, and scube triple MO embryos (scube1-
MOþscube2MOþscube3MO). Statistical analysis demonstrated the phenotypic
enhancement of the youty97 mutant phenotype seen following MO injection is
signiﬁcant. The dramatic loss of slow MyHC positive muscle ﬁbers seen following
scube1MOþscube3MO injection into youty97 homozygotes was equivalent to the loss
of slow MyHC positive muscle ﬁbers seen following scube triple MO injection into
wildtype embryos (l1-3). *ANOVA F(5,137)¼200.11, po0.001. **ANOVA F(5,137)¼
266.10, po0.001. ***ANOVA F(5,137)¼391.35, po0.001. Within each somite region,
bars with different letters are statistically signiﬁcant from one another.
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expression in wildtype embryos (Fig. 3G–I). However, this youty97
phenotype is considerably weaker than the reduction of HH targetgene expression evident in other mutations disrupting the HH
signaling pathway in zebraﬁsh (Hollway et al., 2006; Lewis et al.,
1999; Woods and Talbot, 2005) and is restricted to the posterior
somitic region, correlating with the loss of slow myhc expressing
muscle cells evident within this domain (Figs. 2B, 3J–L). The loss
of slow muscle ﬁbers at all axial levels in scube triple MO embryos
(Fig. 2H) suggested that Scube mediated HH signaling may be
required for speciﬁcation of HH target cells in zebraﬁsh somites.
This possibility was investigated by examining HH target gene
expression (myod, eng, ptc1) within scube triple MO embryos. As
seen for Slow MyHC expression (Fig. 2H), HH target gene expres-
sion was reduced to barely detectable levels at all axial levels in
scube triple MO embryos (Fig. 3M–O) (myod n¼36, ptc n¼38, eng
n¼56). A similar decrease in HH target gene expression occurred
in embryos treated with cyclopamine, a small molecule inhibitor
of smo signaling (Fig. 3P–R), which were stained in parallel.
Similar results were obtained for gene expression analyses
examining the role of scube gene activities in HH dependent
signaling events in neural tissues (Fig. 3S–X00). ptc1 expression is
prominent in the ventral neural tube of the trunk (Fig. 3S–S00)
where its expression is known to be induced by HH signaling
from the midline. In the brain, ptc1 is highly expressed within the
diencephalon (Fig. 3S00), an expression domain induced by HH
signaling from the underlying zona limitans intrathalamica
(Scholpp et al., 2006). In both scube triple MO embryos (Fig. 3T–
T00) and in cyclopamine treated embryos (Fig. 3U–U00) expression
of ptc1 in both these tissue is severely reduced or absent. A second
ventral neural marker foxa2 is also severely reduced in expression
in scube triple MO embryos (Fig. 3V–X00). In wildtype embryos at
26 somites, foxa2 is expressed in ﬂoor plate (Fig. 3V, V0 both
medial and lateral cells) and in two wings of expression in the
ventral diencephalon (Stra¨hle et al., 1996) (arrow, Fig. 3V00). HH
signaling is known to induce formation of the lateral ﬂoor plate
cells and is also required for the maintenance of foxa2 expression
in medial ﬂoor plate cells (Odenthal et al., 2000). In homozygous
youty97 mutants both these foxa2 expression domains are reduced
(Fig. 3W–W00), and in scube triple MO embryos this reduction of
foxa2 expression is more severe (Fig. 3X–X00). Collectively, these
results suggest that Scube proteins are required for normal levels
of HH signaling in vivo, and act redundantly to facilitate HH
signal transduction. Furthermore, the anterior–posterior restric-
tion of the scube1 and scube3 loss of function phenotypes, in
the absence of Scube2 activity suggests a regional requirement
for obligate heterodimerization with Scube2 mediating HH signal
transduction.
Molecular basis of scube function in the HH signal transduction
pathway
Previously, we proposed, based on the secreted nature and
non-cell autonomous action of Scube2, that one possible function
of Scube2 may be at the level of signal reception in the HH signaling
pathway. To further examine the requirement for Scube activity in
HH signal transduction we undertook a series of molecular epistasis
experiments to examine this question in the scube triple MO
context. Ectopic HH pathway activation has been shown to induce
ectopic slow muscle at the expense of fast muscle (Blagden et al.,
1997), as well as inducing ectopic muscle pioneer cells (Currie
and Ingham, 1996; Du et al., 1997; Hammerschmidt et al., 1996),
resulting in excess slow twitch muscle and decreased fast twitch
muscle. One regulatory component of the HH pathway, involved in
the modulation of the Gli transcription factor processing is protein
kinase A (PKA). Injection of RNA encoding a dominant negative
form of PKA (dnPKA) into wildtype embryos resulted in activation
of the HH pathway and ectopic slow myhc expression (n¼100)
(Fig. 4C). If Scube proteins act at the level of HH signal reception
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stream of signal reception, by dnPKA RNA injection, should be
unaffected in scube triple MO embryos. Over-expression of dnPKA
in scube triple MO embryos rescued the loss of slow muscle ﬁbers
seen in scube triple MO embryos, resulting in a slow MyHC
staining pattern equivalent to the pattern seen in dnPKA RNA-
injected wildtype embryos (n¼72) (Fig. 4C, D). This result isconsistent with dnPKA functioning downstream of the Scube
proteins in the HH pathway.
We hypothesized that injection of shh RNA should not be able
to induce formation of slow muscle in scube triple MO embryos if
Scube proteins act in the reception of the HH signal. Surprisingly
however, shh RNA injection into scube triple MO embryos was
also able to partially rescue the loss of slow MyHC expressing
muscle cells (n¼30) (Fig. 4E, F). In order to examine this question
in more detail we injected increasing amounts of shh mRNA into
scube triple MO embryos and compared the ability of these
injections to induce ectopic expression of the shh target gene
myod. We determined that 4 times the amount of shh mRNA is
required to induce ectopic myod expression in scube triple MO
embryos compared to the amount required for wildtype embryos
(Fig. 4K, J, O). These results suggest that although Scube activity is
clearly required for normal levels of HH signaling in vivo, this
need can be bypassed if sufﬁcient ligand is provided.
One explanation for the ability of injected shh mRNA to
activate target gene expression in scube triple MO embryos could
be that global over expression of shh mRNA in every cell of the
developing embryo may induce signaling directly within the cells
that receive it, therefore bypassing the need for Scube activity in
the reception of secreted HH ligand. To test this possibility we
generated small mosaic clones of cells that express SHH fused to
GFP under the control of the pax3a promoter. The pax3a gene is
expressed throughout the psm and the dorsal neural tube at the
stages these cells are competent to respond to activation of HH
signaling. Injection of this construct into wildtype embryos
generated ectopic slow muscle both cell autonomously and non-
cell autonomously (n¼73) (Fig. 4Q–S00) and this ability was not
altered within scube triple MO embryos (n¼30) (Fig. 4T–V00). ThusFig. 3. scube1 and scube3 morpholinos enhance the phenotype of youty97 mutant
embryos. (A–F). Somite shape in live 30 hpf embryos, lateral view anterior to left. (A,
D) The characteristic chevron shape of the wildtype zebraﬁsh somite became
rounded or ‘U’ shaped in the youty97 mutant (B, E). (C, F) Morpholino knockdown
of all 3 scube genes enhanced the youty97 mutant phenotype, a severe loss of the
chevron shape resulted in ‘blocky’ shaped somites. Scale Bars: A–C 150 mm, D–F
100 mm. (G–R). In situ hybridization revealed Hh target gene expression (myod,
patched1 (ptc1), and engrailed (eng)), decreased dramatically in scube triple MO
embryos. (G) myod is expressed in somites and adaxial cells of wildtype embryos,
(J) adaxial expression ofmyod is reduced in youty97 homozygous mutants, (M) adaxial
myod expression is absent from scube triple MO embryo. (P) Adaxialmyod expression
is also absent from cyclopamine treated embryos. (G, J, M, P) Arrows indicate location
of adaxial cells. (H) ptc expression in ventral neural tube and somites in wildtype
embryos. (K) Reduced ptc expression in posterior somites of youty97 embryo,
(N) somitic expression of ptc is absent from scube triple MO and (Q) cyclopamine
treated embryos. (H, K, N, Q) Arrowheads highlight regions of altered gene
expression. (I) In wildtype embryos eng is expressed in the muscle pioneer cells
and a subset of fast muscle ﬁbers, (L) eng expression is reduced in the posterior of
youty97 mutant embryos, (O) in scube triple MO embryos eng expression is severely
reduced with only small patches of eng positive cells visible. (R) Cyclopamine treated
embryos display the most severe loss of eng staining. (I, L, O, R) Arrowheads highlight
regions of altered gene expression. (G, J, M, P) 15 somite stage, dorsal view, (H, K, N,
Q) 22 somite stage, lateral view anterior to left, (I, L, O, R) 26 somite stage, lateral
view, anterior to left. Scale bars: 50 mm. (S–U00) ptc1 expression is reduced in neural
tissue of scube triple MO embryos. In wildtype, uninjected 22 somite embryos (S–S00),
ptc1 expression is prominent in the ventral neural tube of the trunk (S and arrows in
S0) as well as the somites, where its expression is known to be induced by HH
signaling from the midline. In the brain, ptc1 is highly expressed within the
diencephalon (S00 , arrow), an expression domain known to be induced by HH
signaling from the underlying zona limitans intrathalamica. In both scube triple
MO embryos (T–T00) and in cyclopamine treated embryos (U–U00) expression of ptc1
in both these tissues is severely reduced or absent. (V–X00) Expression of the ventral
neural marker foxa2 is severely reduced in scube triple MO embryos. In wildtype
embryos at 26 somites foxa2 is expressed in ﬂoor plate (V, V0 both medial and lateral
cells) and in two wings of expression in the ventral diencephalon (arrow, V0). In
homozygous youty97 mutants both these regions of expression are reduced (Fig. 3W–
W00), and in scube triple MO embryos this reduced expression is greatly enhanced
(X–X00). (S–X00) Within each row, the same letter indicates a different region of the
same embryo.0 Add –(S–X00) anterior to left, (S–U00) 22 somites, lateral view (V,V0 ,
W, W0 , X, X0) 26 somites, lateral view, (V00, W00 , X00) dorsal view.
Fig. 4. Epistatic analysis of scube function in the Hedgehog pathway. Hedgehog pathway overexpression induces ectopic slow MyHC expression in zebraﬁsh embryos.
(A–F). SlowMyHC expression in treated and untreated embryos. (A) SlowMyHC localization in wildtype embryos. (B) scube triple MO embryos show severe reductions in slow
MyHC expression. Representative embryo (B) has 15 slow MyHC positive ﬁbers (arrowheads). (C) Overexpression of dnPKA RNA turns all muscle in the embryo into slow
muscle. (D) Overexpression of dnPKA in scube triple MO embryos rescued the loss of slow muscle seen in scube triple MO embryos. (E) shh RNA overexpression induced
ectopic slow MyHC expression in wildtype embryos. (F) shh RNA overexpression in scube triple MO embryos rescued the loss of slow muscle in scube triple MO embryos.
Lateral views of30 hpf embryos. F59 monoclonal antibody labels slow MyHC positive muscle ﬁbers, Alexa 488 conjugated-donkey anti-mouse secondary antibody,
0.65 Zg of dnPKA RNA and shh RNA was injected at 100 mg/mL. Scale Bars: 100 mm. (G–O) Titration of shh RNA in scube triple MO embryos (G, I, K, M) and uninjected 10
somite embryos (H, J, L, N). Expansion of myod expression is seen at 0.16 ng in embryos not injected with Scube morpholinos (J) compared to 0.65 ng in scube triple MO
embryos (K). (O) Graph showing percentage of embryos with expanded myod expression. (P–V00) Mosaic analysis of cells expressing SHH fused to GFP under the control of the
pax3a promoter. Mosaic expression of pax3a:Shh-GFP generated ectopic slow muscle both cell autonomously (arrows) and non-cell autonomously (arrowheads) in both
wildtype (Q–S00) and scube triple MO embryos (T–V00). (Q, R, S, T, U, V) F59 monoclonal antibody, (Q0 , R0 , S0 , T0 , U0 , V0) anti-GFP antibody, (Q00 , R00, S00, T00, U00 , V00) merged images.
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via endogenous HH, downstream signaling can still be activated
when sufﬁcient ectopic HH ligand is provided. These results
reinforce the idea that Scube activity regulates the bioavailability
or uptake of the HH ligand in target cells.
Zebraﬁsh Scube2 can bind SHH and does not affect formation of
primary cilia
Currently, zebraﬁsh is the only model system in which Scube
activity has been implicated in the control of HH signal transduction
in vivo, andmutations in youmutants remain the only loss of function
models for scube function (Hollway et al., 2006; Kawakami et al.,2005; Woods and Talbot, 2005). Previous studies have shown that
human Scube2 protein can bind to SHH in vitro (Tsai et al., 2009),
therefore it was important to determine whether zebraﬁsh Scube2
can similarly bind SHH. In order to examine this question, we
expressed a version of Scube2 that is Myc tagged at its N-terminus
in culture cells cotransfected with SHH. Previously we had demon-
strated that this version of Scube2 is highly expressed and effectively
secreted in cultured cells (Hollway et al., 2006). Our results demon-
strate that zebraﬁsh Scube2 binds strongly to SHH in vitro in co-
immunoprecipitation assays (Fig. 5), thus conﬁrming that zebraﬁsh
Scube2 is also a SHH binding protein.
We also examined whether scube2 played any role in the
morphogenesis of the primary cilia as modulation of HH signal
Fig. 5. Zebraﬁsh Scube2 binds SHH when co-expressed in COS-1 cells. Binding of
Scube2-Myc to SHH-GFP occurs only in the membrane fraction. COS-1 cells were
transiently transfected with Scube2-Myc and Shh-GFP. As a control, an empty Myc
vector was co-transfected with SHH-GFP. Immunoprecipitation (IP) was per-
formed on lysates and media fractions using anti-Myc antibody. Western blotting
(WB) of immunoprecipitated proteins was performed using anti-GFP (upper
panel) or anti-Myc (lower panel) antibodies.
Fig. 6. Scube activity is not required for primary cilia formation. (A–M) Scube triple MO
somite stage embryos display normal slow muscle development visualized by the slow
by acetylated alpha (a a)-tubulin (green) and gamma (g)-tubulin (red) (Nuclei marked
disrupted slow muscle myogenesis (D, E), yet appear to possess normal primary cilia
organised myotome with chevron shaped somites. (I) In wildtype embryos, cilia are vi
triple MO embryos at 20 somites, myogenesis is disrupted, with somites displaying a U-
(M) appear normal in scube triple MO embryos.
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primary cilia formation (Aanstad et al., 2009; Corbit et al., 2005;
Haycraft et al., 2005; Huangfu and Anderson, 2006; Rohatgi et al.,
2007). Aspects of the scube triple MO phenotype could be explained
by a requirement for Scube activity in formation of primary cilia,
although the non-cell autonomous requirement for Scube activity
in HH target tissues suggests that this would have to act via an
indirect mechanism. However, an evaluation of a subset of primary
cilia in the presomitic mesodern, somites and neural tube of scube
triple MO embryos (n¼40) reveals no difference between wildtype
and triple morphant embryos at either early somite stages, where
HH signaling is known to control speciﬁcation of the primary
myotome or later stages after speciﬁcation of the myotome is
complete (Hirsinger et al., 2004) (Fig. 6A–M).Discussion
In this study we describe the partially redundant function of
the zebraﬁsh scube gene family during HH signal transduction
within the myotome. Scube2 has previously been implicated in
HH signaling during zebraﬁsh myotome development (Hollway
et al., 2006; Kawakami et al., 2005; Woods and Talbot, 2005). Weinjections do not affect formation of primary cilia. (A–C). Water injected control 10
myHC speciﬁc antibody F59. (A, B) Primary cilia are present in the somites, marked
with DAPI) (C). (D–F). 10 somite stage embryos injected with scube triple MO have
(F). (H–J). In control 20 somite embryos (H) slow myHC staining shows a well-
sible in the neural tube (NT) and presomitic mesoderm (PSM) (J). (K–M). In scube
shaped morphology (K). Cilia visible in the neural tube (L) and paraxial mesoderm
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possess three scube genes, orthologous to their mammalian
counterparts. The mRNA expression patterns for the novel zebra-
ﬁsh genes we identiﬁed, scube1 and scube3 overlap signiﬁcantly
with the published expression of scube2, (Hollway et al., 2006;
Kawakami et al., 2005; Woods and Talbot, 2005). The three scube
genes are collectively expressed in the ﬂoorplate, lateral ventral
neural tube, the presomitic mesoderm and within the developing
myotome, regions of the embryo known to be capable of respond-
ing to Hedgehog signaling. However, expression is also evident in
the notochord and precaudal plate mesoderm, tissues known to
secrete HH signals and the ﬂoor plate itself is both patterned by
and secretes HH ligands. Additionally, other expressing tissues,
such as the dorsal neural tube in the case of scube2 and the hind
brain in the case of scube1, neither secrete nor are patterned by
HH signals. Hence, the collective expression of the scube gene
family in zebraﬁsh suggests a potential role in both secretion and
reception of HH ligand, and likely developmental roles independent
of HH signal transduction in a number of tissues. Examination of HH
target gene expression, in embryos knocked down for Scube1, 2 and
3 proteins, demonstrated a more severe loss of HH target gene
expression in triple knockdown embryos than in scube2 mutant
embryos alone both in the forming myotome and the neural
epithelium. The triple morpholino knockdown embryos phenotypi-
cally resembled cyclopamine-treated embryos, a context in which
all HH signaling is believed to be blocked, strongly suggesting all
scube genes are involved in HH signaling. The severe loss of HH
target gene expression in the myotome and neural tube and the lack
of slow MyHC-positive slow muscle ﬁbers, in the triple knockdown
morphants also suggests that at least one functional scube gene is
required for any HH signaling in the myotome.
Interestingly, the three scube genes do not appear to be ‘‘equal’’
in their capacity to compensate and display a regional require-
ment along the embryonic axis. These results suggest that scube2
activity is the most important family member of the group in
modulating HH signaling, as defects in HH sensitive cell types are
only evident when scube1 or scube3 are knocked down in combina-
tion with scube2. The anterior–posterior variability in the severity
of slow MyHC ﬁber loss between the various scube knockdown
combinations is also suggestive of a more complex relationship
than simply functional equivalence of the three Scube proteins.
There is evidence from in vitro experiments, that the Scube proteins
are capable of both homo- and heterodimerization (Wu et al.,
2004; Yang et al., 2002). The overlapping expression patterns of the
three zebraﬁsh scube genes suggest this might also occur in vivo in
zebraﬁsh. Given that scube1 and scube3 cannot fully compensate
for the role of scube2 in slow muscle development, there could be a
functional difference between the three Scube proteins in their
ability to transduce HH signaling. A heterodimer containing Scube2
could be the central mediator of HH signaling in the zebraﬁsh
myotome. The anterior–posterior restriction of the scube1 and
scube3 ﬁber loss phenotypes, in the context of the lack of Scube2
activity, suggests a regional requirement for obligate heterodimer-
ization of Scube1 and Scube3 with Scube2 to mediate HH signal
transduction.
In light of previous experiments, where the requirement for
scube2 was demonstrated in ligand receiving cells for HH signal
transduction (Hollway et al., 2006; Woods and Talbot, 2005), the
ability of ectopic shhmRNA to facilitate slow muscle development
in the absence of scube gene function was unexpected. If, in the
developing myotome, HH receiving cells require Scube function to
mediate the HH signal and induce slow muscle cell fates, ectopic
SHH would not be expected to restore HH signaling in scube triple
knockdown embryos. The ability of SHH to induce ectopic slow
muscle formation both cell autonomously and non cell autono-
mously in the scube triple MO context indicates that a lack ofScube activity can be overcome given sufﬁciently high levels of
ligand. This implies that Scube activity is not obligate for down-
stream signaling and that it may be required to regulate the
‘‘bioavailability’’ of the SHH ligand within responding cells.
Collectively this data is in line with our previously stated model
for Scube function, which was based on the homology between
the Scube protein family and the endocytic receptor Cubilin
(Hollway et al., 2006). An N-terminal fragment of Cubilin encom-
passing only the EGF repeats and the ﬁrst two CUB domains, is
strikingly similar to that encoded by the three scube ORFs, and is
sufﬁcient to bind the endocytic receptor Megalin a known SHH
binding protein (Ahuja et al., 2008; Yammani et al., 2001). On this
basis we suggested a possible endocytic role for Scube proteins in
facilitating internalization of the HH ligand in responding cells, a
process that would be essential for generating signal activation
utilizing endogenous ligand. Conﬁrmation of this model awaits
the results of ongoing studies.Materials and methods
Zebraﬁsh strains
Zebraﬁsh youty97 mutant strain was obtained from H.G. Fron-
hoefer at the Tuebingen Zebraﬁsh Stock Center. TE wildtype
zebraﬁsh were used for morpholino and RNA injections as well
as cyclopamine manipulation.
In situ hybridization, histology and immunohistochemistry
In situ hybridization was performed according to previously
published methods (Oxtoby and Jowett, 1993). Probes used for
in situ hybridization were: engrailed-1 (Hatta et al., 1991); patched-1
(Concordet et al., 1996); shh (Krauss et al., 1993); myod (Weinberg
et al., 1996); foxa2 (Stra¨hle et al., 1996); scube-1 (Fwd: 50-GACGC-
CAAGTGCCACAT GAGAC-30, Rev: 50-GCAACTTCATATGCGGTGCCAG-
30) and scube-3 (Fwd: 50-GAGAGCTGTTCCCTCACGTGTG-30, Rev: 50-
AGCTCCAGAGTAATGCGCGTCA-30). Following in situ hybridization,
embryos were wholemount photographed or wax embedded using
standard procedures (Kiernan, 2005) and 12–14 mm sections cut
using a Leica DCS1 microtome (Leica Microsystems). Embryos were
prepared for immunohistochemistry as described by Blagden et al.
(1997). Antibodies used; F59 (1:50) (Developmental Studies Hybri-
doma Bank, University of Iowa, USA) anti-acetylated alpha tubulin
(1:1000, Sigma), anti-gamma tubulin (1:800, Sigma) and Alexa Fluor
488 conjugated donkey anti-mouse (1:400) (Molecular Probes, USA).
Fiber counting
To quantify the effects of the MO knockdown of scube1 and
scube3 on slow muscle ﬁber formation, F59-positive slow muscle
ﬁbers were counted in 30 hpf embryos. Embryos analyzed:
wildtype (n¼5), youty97 (n¼8), youty97þscube1MO (n¼44), you-
ty97þscube3MO (n¼30), youty97þscube1MOþscube3MO (n¼25),
scube triple MO (scube1MOþscube2MOþscube3MO) (n¼34).
Analysis of variance (ANOVA) was performed using STATA Statis-
tics/Data Analysis version 9.2 (StataCorp), Bonferroni multiple
comparison was used to compare means between the groups.
Immunoprecipitation and western blotting
Scube2-Myc is a C-terminally tagged zebraﬁsh Scube2 construct
and Shh-GFP was a gift from Carol Wicking (IMB, Queensland,
Australia). COS-1 cells, purchased from ATCC, were maintained in
DME, 10% (vol/vol) fetal calf serum containing 2 mM glutamine,
and transfected using the DEAE-dextran procedure and allowed to
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washed with ice-cold PBS and harvested with ice-cold lysis buffer
(1% Triton X-100, 0.5 M NaCl, 50 mM Tris pH 8 and cocktail
inhibitor tablets (Promega)) for 2 h at 4 1C with agitation. Lysates
were centrifuged at 15,400g for 10 min to obtain the Triton
X-100—soluble supernatant which was pre-cleared with Protein
A Sepharose for 1 h at 4 1C with agitation, followed by immuno-
precipitation using tag speciﬁc antibodies and Protein A Sephar-
ose for 2 h at 4 1C with agitation. Immunoprecipitates were
separated by SDS-PAGE, subject to Western transfer and immu-
noblotted with tag speciﬁc antibodies, HA antibody (Covance) and
Myc antibody (Santa Cruz).
Microinjection and embryo manipulation
Embryos were injected according to established methods
(Concordet et al., 1996) using a Narishige IM 300 microinjector
(Leica Microsystems). Morpholinos (GeneTools, USA) scube1MO
(50-CCAGGAGAAGCAGGCAGGACCCATG-30), scube3MO (50-TGCAT-
GAACATCATCGCAAAACACA-30). Non-overlapping ‘B’ morpholinos
were also tested for phenotype consistency: scube1MOB (50-
TTAGAGGCTGTGAGTGAATGGG TCT-30) scube3MOB (50-AAACACC-
TTGAATCTTCAGTGAGAC-30). Five-nucleotide mismatch control
morpholinos (mismatch nucleotides are lower case) scube1-mis-
matchMO (50-TGgATGAAgATgATCcCAAAAgACA-30) and scube3-
mismatchMO (50-CCAcGAcAAGCAGcCAGcACCgATG-30), were used
to conﬁrm speciﬁcity. Varying amounts of each morpholino were
injected; the lethality and phenotypes displayed were compared
to mismatch controls of similar amounts to determine the amount
of morpholino used in this work. 13.9 Zg of scube1MOA and
41.3 Zg of scube3MOA were injected, unless otherwise indicated.
scube2MO injections were performed at 41.1 Zg, equivalent to
previously published concentrations (Hollway et al., 2006) and
phenocopied youty97 mutant embryos.
Capped RNA and DNA injection
Capped RNA for shh (Krauss et al., 1993) and dominant negative
PKA (dnPKA) (Hammerschmidt et al., 1996) were in vitro tran-
scribed using mMessage Machine SP6 kit (Ambion). 0.655 Zg of
dnPKA RNA was injected at 100 mg/mL, shh RNA injected at 25,
100 and 250 mg/mL, was equivalent to 0.16 Zg, 0.65 Zg and
1.63 Zg. 0.655 Zg of Pax-3 promoter DNA constructs were
injected at 100 ug/ml. All injections were performed into one of
the developing blastomeres at the one or two-cell stage.
Cyclopamine treatment
Cyclopamine (Calbiochem) resuspended in 95% ethanol at
10 mM was diluted in aquarium water to 100 mM or 200 mM
and added to late epiboly stage embryos in 12 well plates. An
equal volume of 95% ethanol was diluted in aquarium water
aquarium and added to control embryos. Plates were wrapped in
paraﬁlm and foil to reduce evaporation and exposure to light.
Rapid ampliﬁcation of cDNA ends (RACE)
50 and 30 rapid ampliﬁcation of cDNA ends (RACE) was performed
according to manufacturers protocols for the BD SMART RACE cDNA
ampliﬁcation kit (BD Biosciences Clontech). RACE fragments were
cloned into pGEM-T Easy and sequenced.
Genotyping
Genomic DNA was extracted from MO injected embryos follow-
ing immunohistochemistry. Individual embryos were incubated at50 1C for 6 h in PCR extraction buffer (10 mM Tris pH 8, 2 mM EDTA,
0.2% Triton X-100, 200 mg/mL proteinase K). Proteinase K was heat
inactivated and samples brieﬂy centrifuged. A 484 bp region of
scube2 encompassing the ty97 mutation was ampliﬁed using pri-
mers 50-GATGGAAGTGGGCATTGTAGAC-30 and 50-CTAGTTCAAC-
CATTGGGTGTC-30. PCR products were sequenced with a nested
primer 50-TCCGTACTCTTCGCAAGTC CA-30.
Cloning of the Pax3a-Shh-GFP expression construct
The zebraﬁsh pax3a promoter was sub-cloned from BAC clone
DKEY-20F20 (BACPAC Resources Center, Oakland). Brieﬂy, since the
full sequence of the BAC containing Pax3a exon1 was unavailable we
used a process of semi-random, single primer PCR to isolate the
promoter fragment. The single, low annealing temperature primer 50-
GCGCATCATCCTGGAAAT-30 was designed to extend in the upstream
direction from the ﬁrst exon. PCR reactions were performed using
decreasing annealing temperatures at 2 degree increments between
56 and 42 degrees, such that, at low annealing temperatures the
single primer produced amplicons by sporadic mispriming in the
region upstream of the initiation codon. One robust band of 6.5 kb
was extracted, TA cloned into pGEMT easy (Promega) and end
sequenced for veriﬁcation. This fragment was then subcloned into
the gateway compatible vector pDONRp4-p1R (Invitrogen) to give
the plasmid p5E-Pax3a. The mouse Shh-GFP cassette (a kind gift of
Carol Wicking, IMB Queensland) was cloned into pDONR221 to make
pME-Shh-GFP. Both plasmids were recombined in a single reaction
with pDEST-Tol2-pA2 and p3E-pA from the Tol2 kit to produce the
Pax3a-Shh-GFP cassette.Acknowledgments
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